Trick or TREAT? More condemning evidence against ESAs.
Zarowitz
Barbara J
BJ
Omnicare, Inc., and College of Pharmacy and Allied Health Sciences, Wayne State University, Detroit, MI, USA.
D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D000068256:Darbepoetin alfa; D004921:Erythropoietin / Q000009:adverse effects / Q000031:analogs & derivatives*; D055317:Evidence-Based Practice / Q000458:organization & administration; D006397:Hematinics / Q000009:adverse effects*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D016032:Randomized Controlled Trials as Topic; D006435:Renal Dialysis; D012107:Research Design; D040242:Risk Reduction Behavior; D012449:Safety; D016896:Treatment Outcome
D006397:Hematinics; D004921:Erythropoietin; D000068256:Darbepoetin alfa